placeholder image
G. M. Lee All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: a Vaccine Safety Datalink study. 
    Pharmacoepidemiology and Drug Safety. 2018
  • Identifying birth defects in automated data sources in the Vaccine Safety Datalink. 
    Pharmacoepidemiology and Drug Safety. 2017
  • Live attenuated influenza vaccine use and safety in children and adults with asthma. 
    Annals of Allergy, Asthma, and Immunology. 2017
  • Maternal Tdap vaccination and risk of infant morbidity. 
    Vaccine. 2017
  • Maternal and infant outcomes after human papillomavirus vaccination in the periconceptional period or during pregnancy. 
    Obstetrics and Gynecology. 2017
  • Febrile seizure risk after vaccination in children 6 to 23 months. 
    Pediatrics. 2016
  • Maternal Tdap vaccination: coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013. 
    Vaccine. 2016
  • Risk of anaphylaxis after vaccination in children and adults. 
    Journal of Allergy and Clinical Immunology. 2016
  • Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006. 
    Vaccine. 2015
  • Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barre syndrome, encephalitis, or anaphylaxis in the 2012-2013 season. 
    Pharmacoepidemiology and Drug Safety. 2014
  • Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes. 
    JAMA. 2014
  • Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse events. 
    Vaccine. 2014
  • Timely versus delayed early childhood vaccination and seizures. 
    Pediatrics. 2014
  • A population-based cohort study of undervaccination in 8 managed care organizations across the United States. 
    JAMA pediatrics. 2013
  • Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age. 
    JAMA pediatrics. 2013
  • Guillain-Barre syndrome, influenza vaccination, and antecedent respiratory and gastrointestinal infections: a case-centered analysis in the Vaccine Safety Datalink, 2009-2011. 
    PloS One. 2013
  • Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events. 
    Obstetrics and Gynecology. 2013
  • Maternal safety of trivalent inactivated influenza vaccine in pregnant women. 
    Obstetrics and Gynecology. 2013
  • Mortality rates and cause-of-death patterns in a vaccinated population. 
    American Journal of Preventive Medicine. 2013
  • Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010. 
    Pharmacoepidemiology and Drug Safety. 2013
  • H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project. 
    American Journal of Preventive Medicine. 2011
  • Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink. 
    Archives of Pediatrics and Adolescent Medicine. 2011
  • Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. 
    American Journal of Epidemiology. 2010
    • Editorial Article
  • Financing vaccines for adolescents: a position paper of the society for adolescent health and medicine [editorial]. 
    Journal of Adolescent Health.  48. 2011
    • Review
  • The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety [review]. 
    Vaccine. 2014
    • presentations
    Contact
    full name
  • G. M. Lee
    • Quick Info
     
    Collaboration